1. < Home

Extended-release calcifediol

Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients

Bishop CW, Ashfaq A, Strugnell SA, Choe J, Patel N, Norris KC, Sprague SM. Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol[...]

By afschroeder • July 21, 2026
Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial

Bishop CW, Ashfaq A, Choe J, Strugnell SA, Johnson LL, Norris KC, Sprague SM. Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism[...]

By afschroeder • February 11, 2026
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial

Ashfaq A, Choe J, Strugnell SA, Patel N, Sprague SM, Norris KC, Lerma E, Petkovich PM, Bishop CW, Ashfaq A. Adjunctive Active Vitamin D Decreases[...]

By afschroeder • August 26, 2025